AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients
- 1 June 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 67 (6) , 2440-2447
- https://doi.org/10.1111/j.1523-1755.2005.00352.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chronopharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Occurrence of Acute RejectionThe Journal of Clinical Pharmacology, 2003
- Diabetes Mellitus after Kidney Transplantation in the United StatesAmerican Journal of Transplantation, 2003
- New concepts in cyclosporine monitoringCurrent Opinion in Nephrology and Hypertension, 2002
- C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patientsNephrology Dialysis Transplantation, 2002
- Effective oral administration of tacrolimus in renal transplant recipientsClinical Transplantation, 2001
- Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipientsTransplantation Proceedings, 2001
- Approaching the Therapeutic Window for Cyclosporine in Kidney TransplantationJournal of the American Society of Nephrology, 2001
- Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipientsAmerican Journal of Kidney Diseases, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curveTransplantation Proceedings, 1999